Pregnancy-related recurrent events in thrombophilic women with previous venous thromboembolism.
Simioni
P
P
Tormene
D
D
Prandoni
P
P
Girolami
A
A
D020413:3' Untranslated Regions / Q000235:genetics; D020016:Activated Protein C Resistance / Q000453:epidemiology / Q000235:genetics; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D000991:Antithrombins / Q000172:deficiency / Q000235:genetics; D005165:Factor V / Q000235:genetics; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010298:Parity; D017354:Point Mutation; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000453:epidemiology* / Q000517:prevention & control; D020151:Protein C Deficiency / Q000235:genetics; D018455:Protein S Deficiency / Q000235:genetics; D011516:Prothrombin / Q000235:genetics; D012008:Recurrence; D012307:Risk Factors; D019851:Thrombophilia / Q000453:epidemiology* / Q000235:genetics; D020246:Venous Thrombosis / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control
D020413:3' Untranslated Regions; D000925:Anticoagulants; D000991:Antithrombins; C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin; D006493:Heparin